2MURAKAMI H. Further application of a modified spontaneous emulsification solvent diffusion method to various types of PLGA and PLA polymers for preparation of nanoparticles [ J ]. Powder Technology, 2000,107( 1 ) :137-143.
3VANDERVOORT J, LUDWIG A. Preparation and evaluation of drugloaded gelatin nanoparticles for topical ophthalmic use [ J ]. Eur J Pharm Biopharm,2004,57 (2) :251-261.
1Rodrigues J M, Croft S L, Fessi H, et al. Primaquine-loaded poly (lactide) nanoparticules: physicochemical study and acute tolerancein mice. Int J Pharm, 1995,126:253.
2Santos N S, Magalhaes, Fessi H, et al. An in vitro release kinetic examinationand comparative evaluation between submicron emulsionand polylactic acid nanocapsules of clofibride. J Microencaps, 1995,12:195.
3Marchais H, Benali S, Irache J M, et al. Entrapment efficiencyand initial release of phenylbutazone from nanocapsulesprepared from different polyesters. Drug Dev Ind Pharm, 1998, 24:883.
4Cauchetier E, Deniau M, Fessi H, et al. Atovaquone-loaded nanocapsules: influence of the nature of the polymer on their in vitro characteristics. Int J Pharm, 2003, 50:273.
5Paul M, Fessi H, Laatiris A, et al. Pentamidine-loaded poly(d,l-lactide) nanoparticles:physicochemical properties and stability work. Int J Pharm, 1997, 159:223.
6Verger M L, Fluckiger L, Kim Y, et al. Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur J Pharm, 1998,46:137.
7.卫生部药品标准: 第十九册.[S].,1998.224.
8Urata T,Arimori K, Nakano H, et al. Modification of release rates of cyclosporin A from polyl( L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres [J]. J Controlled Release, 1999,58 (2): 133.
